logo-loader

Elixinol Global 'only company in the sector to list a profit'

Last updated: 12:27 07 Sep 2018 AEST, First published: 22:27 06 Sep 2018 AEST

Elixinol Global Ltd (ASX:EXL) executive director & CEO Paul Benhaim speaks to Proactive Investors about the cannabis group of companies’ business sectors and suite of hemp-based foods, supplements and medicinal oil products.
 
The group’s portfolio comprises three main divisions: Elixinol USA focused on dietary supplements; Hemp Foods Australia selling food products; and Elixinol Australia, the new start-up focused on medicinal cannabis.
 
“Elixinol Global listed in January this year on the ASX and we did that to raise about $20 million which was a highly oversubscribed listing,” Benhaim says.
 
He continues, “those funds were intended to be used on the medical cannabis business start-up in Australia … that business has applied for licences with the Office of Drug  Control, which we’re currently waiting for.”
 
Recently announced half-year results show Elixinol Global grew over 110% on the prior period, with first-half revenue of $14.9 million.

Australian Strategic Materials signs US$600 million LoI

Rowena Smith, CEO and managing director of Australian Strategic Materials Ltd (ASX:ASM, OTC:ASMMF), joins Jonathan Jackson in the Proactive studio to discuss the company’ s Dubbo Project, in Central West New South Wales. This project aims to extract and process critical minerals and rare earth...

6 hours, 12 minutes ago